DelMar Pharma Partners With Wuzhou Pharma on Cancer Drug

Published: Dec 14, 2012

by Richard Daverman, PhD

December 13, 2012 -- DelMar Pharma, a virtual company based in Vancouver, is developing a treatment for cancer. It partnered with Guangxi Wuzhou Pharma, which was already marketing the drug to the China market. Initially, DelMar established a supplier relationship with Wuzhou, and then expanded the partnership in October into a more far-reaching collaboration. In an exclusive interview with ChinaBio® Today, CEO Jeffrey Bacha discusses DelMar and his experience partnering with his China counterpart. More details....

Back to news